Product Program year 2019 Source: CMS Open Payments

Thymoglobulin

Drug Oncology

NDC 58468-0080-1

Open in the dashboard

General payments

$436,352

459 payments

Research payments

$78,833

4 payments

Through program year 2019, $436,352 in general payments and $78,833 in research payments were reported against Thymoglobulin (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $436,352 459
2019 Research $78,833 4

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $372,086 403 payments
  2. Sanofi-Aventis U.S. LLC $64,265 56 payments
Top recipients General payments · program year 2019
  1. Dorry Segev Surgery · Baltimore, MD $135,632 31% · 87 payments
  2. Ervin Woodle Transplant Surgery · Cincinnati, OH $29,839 7% · 29 payments
  3. Jason Wellen Transplant Surgery · Saint Louis, MO $22,523 5% · 20 payments
  4. Krista Lentine Nephrology · Saint Louis, MO $19,850 5% · 20 payments
  5. Daniel Brennan Nephrology · Baltimore, MD $15,310 4% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Surgery $144,086 41% · 23 practitioners
  2. Transplant Surgery $92,089 26% · 40 practitioners
  3. Nephrology Internal Medicine $76,675 22% · 68 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $10,478 3% · 1 practitioner
  5. Internal Medicine $10,299 3% · 9 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Maryland $150,959 35% · 3 recipients
  2. California $43,363 10% · 12 recipients
  3. Missouri $42,475 10% · 4 recipients
  4. Ohio $35,739 8% · 3 recipients
  5. New York $21,079 5% · 29 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

459 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record